Open Outbreak

Measles

Also known as: rubeola, morbillivirus, morbilli, red measles

Measles is a very contagious viral infection that spreads through the air and through droplets from an infected person’s nose, mouth, or throat. WHO says symptoms usually start about 10 to 14 days after infection. Early signs include high fever, cough, runny nose, red eyes, and small white spots inside the mouth, followed by a rash that spreads from the head downward. Most people recover in two to three weeks, but measles can cause pneumonia, diarrhoea, ear infection, brain inflammation, blindness, and death. WHO notes that about two or three deaths may occur for every 1000 reported cases, although outbreak fatality ratios can be higher in settings with malnutrition, weak health systems, or low vaccination coverage. There is no specific antiviral treatment for routine measles. Care is supportive, and WHO outbreak reports emphasize vaccination to prevent illness and complications. Two doses of measles-containing vaccine are the main protection, but recent WHO notices show that outbreaks still happen when vaccination coverage falls.

Key facts

TransmissionAirborne and via droplets from the nose, mouth, or throat of infected persons; infectious from 4 days before to 4 days after rash onset.
IncubationUsually 10 to 14 days after infection or exposure.
Case fatalityWHO states about 2 to 3 deaths per 1000 reported cases in general; recent outbreak CFRs reported by WHO include 0.14% in Nepal (2023), 1.06% in South Sudan (2023), 1.1% in Ethiopia (2021-2023 period reported in 2023), and 0.9% in Bangladesh (2026).
Reproduction numberR0 12 to 18 in a 2024 review.
VaccineYes. WHO states measles is preventable with two doses of vaccine; outbreak reports refer to measles-containing vaccine and MMR/MR campaigns.
TreatmentNo specific antiviral treatment for routine measles in the WHO source used. Management is supportive; WHO outbreak reports also emphasize prevention of complications and vaccination response. Vitamin A is used in practice, but the retrieved sources here did not give a treatment standard with dosing.
Reservoirunknown
Endemic regionsStill endemic in many parts of the world; WHO outbreak notices specifically describe endemic transmission in parts of Africa and Asia, including Ethiopia and Indonesia.

Transmission

Measles spreads very easily from person to person. WHO says it is an airborne viral disease and can also spread through droplets from the nose, mouth, or throat of an infected person. A person can pass it on from four days before the rash appears until four days after the rash starts. That matters because people can be infectious before measles is obvious. WHO also noted in a 2023 measles item that about 90% of non-immune people exposed to an infectious person are estimated to become infected. A 2024 review found a basic reproduction number, or R0, of 12 to 18, which is one reason outbreaks can grow quickly when vaccination coverage drops. WHO’s recent notices in the Americas and the United States repeatedly link outbreaks to unvaccinated people and to imported cases that then spread in under-vaccinated communities.

Symptoms and severity

WHO says the first symptoms usually appear 10 to 14 days after infection. Early symptoms include high fever, runny nose, bloodshot eyes, cough, and tiny white spots inside the mouth. The rash usually appears after that and spreads from the head to the trunk and then to the legs. Most people recover within two to three weeks, but measles is not always mild. WHO lists pneumonia, diarrhoea, secondary ear infection, inflammation of the brain, blindness, and death as possible complications. In the 2025 United States outbreak notice, WHO states that post-infectious encephalitis can occur in about one in every 1000 reported cases, and about two or three deaths may occur for every 1000 reported cases. Outbreak severity varies by setting. WHO-reported case fatality ratios were 0.14% in Nepal in 2023, 1.06% in South Sudan in 2023, 1.1% in Ethiopia in 2023 reporting, and 0.9% in Bangladesh in 2026.

Treatment and vaccines

The main protection is vaccination. WHO says measles is preventable with two doses of vaccine, and recent outbreak reports describe use of MMR vaccine in the Americas and measles-rubella vaccination campaigns in countries such as Bangladesh and Morocco. In the United States, WHO reported kindergarten coverage for two MMR doses was 92.7% in 2023, below the 95% level often needed to block spread reliably in communities. For treatment, WHO says there is no specific antiviral treatment for measles and that most people recover in two to three weeks. Care is therefore supportive and focused on complications such as pneumonia, dehydration, or severe illness. WHO outbreak reports also stress case management, surveillance, and rapid catch-up vaccination. Some clinical literature discusses ribavirin, but the review retrieved here describes the evidence as controversial, so it cannot be treated as standard therapy based on these sources alone.

Where it occurs

Measles can appear anywhere if the virus is imported into a community with enough susceptible people. WHO says the disease remains endemic in many parts of the world. Recent WHO notices show both patterns at once: endemic circulation in some countries, and reintroduction or import-related outbreaks in places that had interrupted endemic transmission. WHO described measles as endemic in Ethiopia and Indonesia, with cases reported every year. In contrast, Chile’s 2023 case was imported, and WHO noted that the United States eliminated endemic measles in 2000 but still detects imported cases because measles remains endemic elsewhere. In 2025, WHO reported confirmed measles cases across six countries in the Region of the Americas, with most cases imported or linked to importation. This means location matters less than immunity gaps: where two-dose coverage falls, measles can return quickly.

Recent history

This site’s archive lists 31 measles-related WHO notices or major events since 1996, which shows that measles is a recurring global public-health problem rather than a rare one-off event. The recent pattern is resurgence after gaps in vaccination and surveillance. WHO reported large national outbreaks in South Sudan, Nepal, South Africa, Indonesia, Ethiopia, Morocco, and Bangladesh. In the Americas, WHO reported 2318 confirmed cases and three deaths across six countries from 2025-01-01 to 2025-04-18, an 11-fold increase over the same period in 2024. WHO also reported a United States outbreak with 378 cases and two deaths from 2025-01-01 to 2025-03-20, the first measles deaths in the country in a decade. Bangladesh reported 19 161 suspected cases, 2897 laboratory-confirmed cases, and 166 measles-related deaths between 2026-03-15 and 2026-04-14. The common thread in these notices is under-vaccination, importation, and spread in children and other unprotected groups.

What to watch

The most worrying signals are clear in WHO’s recent outbreak notices. First, watch for spread into new regions or return in places that had eliminated endemic measles, especially when cases are imported and then keep spreading locally. Second, watch for signs of sustained transmission in under-vaccinated communities, including clusters in schools, religious gatherings, or displaced populations. Third, watch for severe outcomes: more hospitalizations, pneumonia, encephalitis, or rising case fatality ratios, especially in children under 5 years, malnourished groups, or people with weak immune systems. Fourth, watch vaccine coverage and campaign reach. WHO repeatedly links outbreaks to unvaccinated people or unknown vaccination status, and notes that more than 22 million children worldwide missed a first dose in 2023. Fifth, watch for any WHO report of reduced vaccine effectiveness or viral change. In March 2025, WHO said there was no evidence of decreased vaccine effectiveness or increased severity in the United States outbreak, which is reassuring but worth continued monitoring.

Related outbreaks

Updated